Skip to main content
SpringerLink
Log in

Clinical Pharmacokinetics of Amantadine Hydrochloride

  • Review Article
  • Published:
Clinical Pharmacokinetics Aims and scope Submit manuscript

Summary

Amantadine is a drug with diverse uses ranging from prevention of influenza A illness to the treatment of patients with Parkinson’s disease. It is available only in oral formulations from which it is well absorbed and widely distributed, little drug being present in the circulation. Apparent volume of distribution is inversely related to dose over the therapeutic range and accounts in part for a noteworthy logarithmic increase in plasma concentration as a function of dose. Elimination is primarily by renal clearance by both glomerular filtration and tubular secretion.

Amantadine accumulates in patients with renal dysfunction. Hence, doses must be reduced in such patients to avoid toxicity. Interactions with other drugs appear uncommon.

Relationships have been demonstrated between amantadine therapeutic effects and plasma concentrations in different study cohorts, but not in individual patients. Dose schedules have been suggested for individuals in whom amantadine kinetics are different from healthy subjects. However, these schedules are controversial in their choice of target concentrations and in being untested as to predictive value.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Alvan G, Kugelberg U, Sundqvist A, Tomson T. Amantadinin-toxikation vid njurinsufficiens. Lakartidningen 77: 3650, 1980

    PubMed  CAS  Google Scholar 

  • Aoki FY, Sitar DS. Amantadine kinetics in healthy elderly men: implications for influenza prevention. Clinical Pharmacology and Therapeutics 37: 137–144, 1985

    Article  PubMed  CAS  Google Scholar 

  • Aoki FY, Sitar DS. Amantadine toxicity during influenza A prophylaxis. Correspondence. Archives of Internal Medicine 147: 1189, 1987a

    Article  PubMed  CAS  Google Scholar 

  • Aoki FY, Sitar DS. Effects of chronic amantadine hydrochloride ingestion on its and paracetamol pharmacokinetics in young adults. Submitted for publication, 1987b

  • Aoki FY, Sitar DS, Ogilvie RI. Amantadine kinetics in healthy young subjects after long-term dosing. Clinical Pharmacology and Therapeutics 26: 727–736, 1979

    Google Scholar 

  • Aoki FY, Stiver HG, Sitar DS, Boudreault A, Ogilvie RI. Prophylactic amantadine dose and plasma concentration-effect relationships in healthy adults. Clinical Pharmacology and Therapeutics 37: 128–136, 1985

    Article  PubMed  CAS  Google Scholar 

  • Armbruster KFW, Rahn AC, Ing TS, Halper IS, Dyama JH, et al. Amantadine toxicity in a patient with renal insufficiency. Nephron 13: 183–186, 1974

    Article  PubMed  CAS  Google Scholar 

  • Atkinson WL, Arden NH, Patriarca PA, Leslie N, Lui K-J, et al. Amantadine prophylaxis during an institutional outbreak of type A (HINI) influenza. Archives of Internal Medicine 146: 1751–1756, 1986

    Article  PubMed  CAS  Google Scholar 

  • Belanger PM, Grech-Belanger D. Gas-liquid chromatographic determination of plasma and urinary levels of amantadine in man. Journal of Chromatography 228: 327–332, 1982

    Article  PubMed  CAS  Google Scholar 

  • Belanger PM, Grech-Belanger O, Labadie R. Depression of hepatic microsomal enzyme systems by amantadine hydrochloride in the rat. Journal of Pharmacology and Experimental Therapeutics 211: 485–490, 1979

    PubMed  CAS  Google Scholar 

  • Biandrate P, Tognoni G, Belvedere G, Frigerio A, Rizzo M, et al. A gas chromatographic method for the determination of amantadine in human plasma. Journal of Chromatography 74: 31–34, 1972

    Article  PubMed  CAS  Google Scholar 

  • Bleidner WE, Harmon JB, Hewes WE, Lynes TE, Hermann EC. Absorption, distribution and excretion of amantadine hydrochloride. Journal of Pharmacology and Experimental Therapeutics 150: 484–490, 1965

    PubMed  CAS  Google Scholar 

  • Blye E, Lorch J, Cortell S. Extracorporeal therapy in the treatment of intoxication. American Journal of Kidney Diseases 3: 321–338, 1984

    PubMed  CAS  Google Scholar 

  • Borison RL. Amantadine-induced psychosis in a geriatric patient with renal disease. American Journal of Psychiatry 136: 111–112, 1979

    PubMed  CAS  Google Scholar 

  • Bryson YJ, Monahan C, Pollack M, Shields WD. A prospective double-blind study of side effects associated with the administration of amantadine for influenza A virus prophylaxis. Journal of Infectious Diseases 141: 543–547, 1982

    Article  Google Scholar 

  • Centers for Disease Control, Department of Health and Human Sciences. Recommendations for prevention and control of influenza. Annals of Internal Medicine 105: 399–404, 1986

    Google Scholar 

  • Chopra YM, Dandiya PC. Potentiation of anticatatonic effect of antidepressants by amantadine. Indian Journal of Medical Research 66: 142–149, 1977

    PubMed  CAS  Google Scholar 

  • Crispens CG. Handbook on the laboratory mouse, pp. 82–90, Charles C. Thomas, Springfield, 1975

    Google Scholar 

  • Daugirdas JT, Ing IL, Cheng PJ, Wu MJ, Klawans HL, et al. Binding of amantadine to red blood cells. Therapeutic Drug Monitoring 6: 399–401, 1984

    Article  PubMed  CAS  Google Scholar 

  • DiMascio A, Bernardo DL, Greenblatt DJ, Marder JE. A controlled trial of amantadine in drug-induced extrapyramidal disorders. Archives of General Psychiatry 33: 599–602, 1976

    Article  PubMed  CAS  Google Scholar 

  • Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, et al. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. New England Journal of Medicine 307: 580–584, 1982

    Article  PubMed  CAS  Google Scholar 

  • Dourmashkin R, Tyrrell DAJ. Electron microscope observations on the entry of influenza virus into susceptible cells. Journal of General Virology 24: 129–141, 1974

    Article  PubMed  CAS  Google Scholar 

  • Fahn S, Craddock G, Kumin G. Acute toxic psychosis from suicidal over-dosage of amantadine. Archives of Neurology 25: 45–48, 1971

    Article  PubMed  CAS  Google Scholar 

  • Farnebo LO, Fuxe K, Goldstein M, Manberg B, Ungerstedt U. Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson’s disease. European Journal of Pharmacology 16: 27–38, 1971

    Article  PubMed  CAS  Google Scholar 

  • Fasano VA, Urciuoli R, Broggi G. Prime osservazioni sull’uso dell’Amantadina per via endovenosa e delle associazione dell’Amantadina per via orale con farmaci anticolinergici e con levo-dopa nel trattamento della malattia di Parkinson. Minerva Medica (Torino) 61: 2895–2903, 1970

    CAS  Google Scholar 

  • Fenton RJ, Bessell C, Spilling CR, Potter CW. The effects of peroral or local aerosol administration of 1-aminoadamantane hydrochloride (amantadine hydrochloride) on influenza infections of the ferret. Journal of Antimicrobial Chemotherapy 3: 463–472, 1977

    Article  PubMed  CAS  Google Scholar 

  • Finklea JF, Hennessy AV, Davenport FM. A field trial of amantadine prophylaxis in naturally occurring acute respiratory illness. American Journal of Epidemiology 65: 403–412, 1967

    Google Scholar 

  • Geuens HF, Stephens RL. Influence of the pH of the urine on the rate of excretion of 1-adamantanamine. 5th International Congress of Chemotherapy, Vienna, June 26–July 1, 1967, pp. 703–713, Verlag der Wiener Medizinischen Akademie, Vienna, 1967

    Google Scholar 

  • Gill MJ, Sitar DS, Aoki FY. Initial pharmacokinetic evaluation of amantadine hydrochloride administered intravenously to young healthy volunteers. Abstract. Clinical and Investigative Medicine 5: 5B, 1982

    Google Scholar 

  • Greenblatt DJ, Dimasco A, Harmatz JS, Bernardo DL, Marder JE. Pharmacokinetics and clinical effects of amantadine in drug-induced extra-pyramidal symptoms. Journal of Clinical Pharmacology 17: 704–708, 1977

    PubMed  CAS  Google Scholar 

  • Grelak RP, Clark R, Stump JM, Vernier VG. Amantadine-dopamine interaction: possible mode of action in Parkinsonism. Science 169: 203–204, 1970

    Article  PubMed  CAS  Google Scholar 

  • Hayden FG, Gwaltney Jr JM, Van De Castle RL, Adams KF, Giordani B. Comparative toxicity of amantadine hydrochloride and rimantadine hydrochloride in healthy adults. Antimicrobial Agents and Chemotherapy 19: 226–233, 1981

    Article  PubMed  CAS  Google Scholar 

  • Hayden FG, Hall WJ, Douglas Jr RG, Speers DM. Amantadine aerosols in normal volunteers: pharmacology and safety testing. Antimicrobial Agents and Chemotherapy 16: 644–650, 1979

    Article  PubMed  CAS  Google Scholar 

  • Hayden FG, Hoffman HE, Spyker DA. Differences in side effects of amantadine hydrochloride and rimantadine hydrochloride relate to differences in pharmacokinetics. Antimicrobial Agents and Chemotherapy 23: 458–464, 1983

    Article  PubMed  CAS  Google Scholar 

  • Hayden FG, Minocha A, Spyker DA, Hoffman HE. Comparative single-dose pharmacokinetics of amantadine hydrochloride and rimantadine hydrochloride in young and elderly adults. Antimicrobial Agents and Chemotherapy 28: 216–221, 1985

    Article  PubMed  CAS  Google Scholar 

  • Horadam VW, Sharp JG, Smilack JD, McAnalley BH, Garriott JC, et al. Pharmacokinetics of amantadine hydrochloride in subjects with normal and impaired renal function. Annals of Internal Medicine 94: 454–458, 1981

    PubMed  CAS  Google Scholar 

  • Ing TS, Cheng PJ, Wu MJ, Daugirdas JT, Soung LS. Plasma protein-binding of amantadine in maintenance hemodialysis patients. International Journal of Artificial Organs 7: 235, 1984

    PubMed  CAS  Google Scholar 

  • Ing TS, Daugirdas JT, Soung LS, Klawans HL, Mahurkar SD, et al. Toxic effects of amantadine in patients with renal failure. Canadian Medical Association Journal 120: 695–698, 1979

    PubMed  CAS  Google Scholar 

  • Jackson GG, Stanley ED, Muldoon RL. Chemoprophylaxis of viral respiratory diseases. 1st International Conference on Vaccines against Viral and Rickettsial Diseases of Man, p. 595, Scientific publication no. 147, Pan American World Health Organization, Washington, DC, 1967

    Google Scholar 

  • Johnson RG, Carty SE, Scarpa A. Accumulation of amantadine by isolated chromaffin granules. Biochemical Pharmacology 30: 763–769, 1981

    Article  PubMed  CAS  Google Scholar 

  • Kelly JT, Zimmerman RL, Abuzzahab FS, Schiele BC. A double-blind study of amantadine hydrochloride versus benztropine mesylate in drug-induced Parkinsonism. Pharmacology 12: 65–73, 1974

    Article  PubMed  CAS  Google Scholar 

  • Knight V, Bloom K, Wilson SZ, Wilson RK. Amantadine aerosol in humans. Antimicrobial Agents and Chemotherapy 16: 572–578, 1979

    Article  PubMed  CAS  Google Scholar 

  • Koppel C, Tenczer J. A revision of the metabolic disposition of amantadine. Biomedical Mass Spectrometry 12: 499–501, 1985

    Article  PubMed  CAS  Google Scholar 

  • Leeming JK. Amantadine hydrochloride and the elderly. Lancet 1: 313–314, 1969

    CAS  Google Scholar 

  • Liu P, Cheng PJ, Ing TS, Daugirdas JT, Jeevanandhan R, et al. In vitro binding of amantadine to plasma proteins. Clinical Neuropharmacology 7: 149–151, 1984

    Article  PubMed  CAS  Google Scholar 

  • Merrick EM, Schmitt PP. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel®). Current Therapeutic Research 15: 552–558, 1973

    PubMed  CAS  Google Scholar 

  • Messiha FS. Antagonism of ethanol-evoked responses by amantadine: a possible clinical application. Pharmacology Biochemistry and Behavior 8: 573–577, 1978

    Article  CAS  Google Scholar 

  • Mindham RHS, Gaind R, Anstee BH, Rimmer L. Comparison of amantadine, orphenadrine, and placebo in the control of phenothiazine-induced Parkinsonism. Psychological Medicine 2: 406–413, 1972

    Article  PubMed  CAS  Google Scholar 

  • Montanari C, Ferrari P, Bavazzano A. Urinary excretion of amantadine by the elderly. European Journal of Clinical Pharmacology 8: 349–351, 1975

    Article  PubMed  CAS  Google Scholar 

  • Monto AS, Gunn RA, Bandyk MG, King CL. Prevention of Russian influenza by amantadine. Journal of the American Medical Association 241: 1003–1007, 1979

    Article  PubMed  CAS  Google Scholar 

  • O’Malley K, Stevenson IH, Turnbull MJ. Amantadine and drug metabolism. Lancet 1: 685, 1972

    Article  PubMed  Google Scholar 

  • Oxford JS, Galbraith A. Antiviral activity of amantadine: a review of laboratory and clinical data. Pharmacology and Therapeutics 11: 181–262, 1980

    Article  PubMed  CAS  Google Scholar 

  • Pacifici GM, Nardini M, Ferrari P, Latini R, Fieschi C, et al. Effects of amantadine on drug-induced Parkinsonism: relationship between plasma levels and effect. British Journal of Clinical Pharmacology 3: 883–889, 1976

    Article  PubMed  CAS  Google Scholar 

  • Parkes D. Amantadine. Advances in Drug Research 8: 8–11, 1974

    Google Scholar 

  • Parkes JD, Zilha KJ, Marsden P, Baxter RCH, Knill-Jones RP. Amantadine dosage in treatment of Parkinson’s disease. Lancet 1: 1130–1133, 1970

    Article  PubMed  CAS  Google Scholar 

  • Peacocke J, Eadie J. Influenza. Canada Diseases Weekly Report 6: 242–243, 1980

    Google Scholar 

  • Perrin DD, Hawkins I. The dissociation constant of the 1-amino-adamantane cation. Experientia 28: 880, 1972

    Article  CAS  Google Scholar 

  • Postma JU, Van Tilburg W. Visual hallucinations and delirium during treatment with amantadine (Symmetrel). Journal of the American Geriatrics Society 23: 212–215, 1975

    PubMed  CAS  Google Scholar 

  • Quilligan Jr JJ, Hirayama M, Baernstein Jr MD. The suppression of A2 influenza in children by the chemoprophylactic use of amantadine. Journal of Pediatrics 69: 572–575, 1966

    Article  PubMed  Google Scholar 

  • Renkin EM, Robinson RR. Glomerular filtration. New England Journal of Medicine 290: 785–792, 1974

    Article  PubMed  CAS  Google Scholar 

  • Richman DD, Yazaki P, Hostetier KY. The intracellular distribution and antiviral activity of amantadine. Virology 112: 81–90, 1981

    Article  PubMed  CAS  Google Scholar 

  • Rizzo M, Biandrate P, Tognoni G, Morselli PL. Amantadine in depression: relationship between behavioural effects and plasma levels. European Journal of Clinical Pharmacology 5: 226–228, 1973

    Article  CAS  Google Scholar 

  • Schwab RS, England Jr AC, Poskanzer DC, Young RR. Amantadine in the treatment of Parkinson’s disease. Journal of the American Medical Association 208: 1168–1170, 1969

    Article  PubMed  CAS  Google Scholar 

  • Sioufi A, Pommier F. Gas chromatographic determination of amantadine hydrochloride (Symmetrel) in human plasma and urine. Journal of Chromatography 183: 33–39, 1980

    Article  PubMed  CAS  Google Scholar 

  • Skehel JJ, Hay AJ, Armstrong JA. On the mechanism of inhibition of influenza virus replication by amantadine hydrochloride. Journal of General Virology 38: 97–110, 1978

    Article  PubMed  CAS  Google Scholar 

  • Smith CB, Purcell RH, Chancock RM. Effect of amantadine hydrochloride on parainfluenza type 1 virus infections in adult volunteers. American Review of Respiratory Diseases 95: 689–690, 1967

    CAS  Google Scholar 

  • Smorodintsev AA, Zlydnikov DM, Kiseleva AM, Romanov JA, Kazantsev AP, et al. Evaluation of amantadine in artificially induced A2 and B influenza. Journal of the American Medical Association 213: 1448–1454, 1970

    Article  PubMed  CAS  Google Scholar 

  • Solovyov VN, Tolmacheva NS. Therapeutic effect of amantadine aerosol in experimental influenza infection of white mice. Acta Virology 11: 482–487, 1967

    CAS  Google Scholar 

  • Soung L-S, Ing TS, Daugirdas JT, Wu M-J, Gandhi VC, et al. Amantadine hydrochloride pharmacokinetics in hemodialysis patients. Annals of Internal Medicine 93: 46–49, 1980

    PubMed  CAS  Google Scholar 

  • Stumph MJ, Noall MW, Knight V. Gas-chromatographic determination of amantadine in human urine. Clinical Chemistry 26: 295–296, 1980

    PubMed  CAS  Google Scholar 

  • Taylor Dickinson PC, Chang TW, Weinstein L. Effects of amantadine on influenza B and measles virus infection in children. In Proceedings of the 6th Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Philadelphia, Oct 26–28, 1966. pp. 521–526, 1967

  • Tilles JG. Antiviral agents. Annual Review of Pharmacology 14: 469–489, 1974

    Article  CAS  Google Scholar 

  • Tyrrell DAJ, Bynoe ML, Hoorn B. Studies on the antiviral activity of 1-adamantanamine. British Journal of Experimental Pathology 46: 370–375, 1965

    PubMed  CAS  Google Scholar 

  • Uchiyama M, Shibuya M. Distribution and excretion of 3H-amantadine HCl. Chemical and Pharmaceutical Bulletin 17: 841–843, 1969

    Article  CAS  Google Scholar 

  • Vernier VG, Harmon JB, Stump JM, Lynes TE, Marvel JP, et al. The toxicologic and pharmacologic properties of amantadine hydrochloride. Toxicology and Applied Pharmacology 15: 642–665, 1969

    Article  PubMed  CAS  Google Scholar 

  • Walker JS, Stephen EL, Spertzel RO. Small particle aerosols of antiviral compounds in treatment of type A influenza pneumonia in mice. Journal of Infectious Diseases 133 (Suppl.): A140–144, 1976

    Article  PubMed  Google Scholar 

  • Wesemann VW, Schollmeyer JD, Sturm G. Gaschromatographische und massenspektrometrische Untersuchungen uber harnpflichtige Metabolite von Adamantanaminen. Arzneimittel-Forschung 27: 1471–1477, 1977

    PubMed  CAS  Google Scholar 

  • Wilson TW, Rajput AH. Amantadine-Dyazide interaction. Canadian Medical Association Journal 129: 974–975, 1983

    PubMed  CAS  Google Scholar 

  • Wright PF, Khan KT, Oxman MN, Schwachman H. Evaluation of the safety of amantadine HCI and the role of respiratory viral infections in children with cystic fibrosis. Journal of Infectious Diseases 134: 144–149, 1976

    Article  PubMed  CAS  Google Scholar 

  • Wu MJ, Ing TS, Soung LS, Daugirdas JT, Hano JE, Gandhi VC. Amantadine hydrochloride pharmacokinetics in patients with impaired renal function. Clinical Nephrology 17: 19–23, 1982

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sections of Clinical Pharmacology and Infectious Diseases, Faculty of Medicine, University of Manitoba, Winnipeg, Canada

    Fred Y. Aoki & Daniel S. Sitar

Authors
  1. Fred Y. Aoki
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel S. Sitar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Aoki, F.Y., Sitar, D.S. Clinical Pharmacokinetics of Amantadine Hydrochloride. Clin-Pharmacokinet 14, 35–51 (1988). https://doi.org/10.2165/00003088-198814010-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00003088-198814010-00003

Keywords

Search

Navigation